Cheryl Ho, MD, FRCP(C)
Clinical Assistant Professor of Medicine, UBC
Medical Oncologist, BC Cancer
Cheryl Ho is a clinical assistant professor at the University of British Columbia and a medical oncologist at British Columbia Cancer.
She is currently the provincial systemic chair for head and neck malignancies.
She completed medical school and internal medicine training at the University of Western Ontario.
She is a graduate of the BC Cancer Agency Medical Oncology program and completed a fellowship in Thoracic Oncology at University of California, Davis.
Her current practice focuses on the treatment of thoracic and head and neck malignancies.
Barbara Melosky, MD, FRCP(C)
Professor of Medicine, UBC
Medical Oncologist, BC Cancer
Dr. Melosky is a Professor of Medicine at the University of British Columbia and a Medical Oncologist at the British Columbia Cancer Agency.
She graduated from medical school at the University of Manitoba and did a residency in internal medicine at the University of British Columbia.
She is currently a medical oncologist at BC Cancer with clinical interests in GI and respiratory malignancies.
She is also the chairperson of the Colorectal Screening Program of British Columbia and has a special interest in EGFR receptors and management of side effects.
Randeep Sangha, MD, FRCPC
Medical Oncologist, Cross Cancer Institute
Assistant Professor, University of Alberta
Dr. Sangha is an Associate Professor in the Department of Oncology at the University of Alberta and Medical Oncologist at the Cross Cancer Institute, Edmonton, AB. He is the Provincial Lead for the Alberta Lung Cancer Program.
Dr. Sangha received his medical degree at the University of Alberta and subsequently specialized in Internal Medicine and Medical Oncology. He completed two years of post-fellowship training in thoracic oncology at the University of California, Davis Comprehensive Cancer Center.
His academic, clinical, and educational activities revolve around thoracic and hematological malignancies. He is also experienced in Investigational New Drug (Phase I) development and is actively involved in the Phase I clinical trials program at the Cross Cancer Institute.
Martin Robert Chasen, MBChB, FCP(SA), MPhil(Pall Med)
Associate Professor, Division of Palliative Care, University of Ottawa
Medical Director, Palliative Care,
William Osler Health System
Medical Director, Palliative Rehabilitation, Élisabeth Bruyère Hospital
Dr. Martin Chasen is currently the Medical Director of Palliative Care, at William Osler Health System in Brampton. He was previously Medical Director, Palliative Care, at The Ottawa Hospital Cancer Centre and the Palliative Rehabilitation Program at Élisabeth Bruyère Hospital, Ottawa.
Dr. Chasen, born in Pretoria, South Africa completed his undergraduate training in medicine and surgery at the University of Pretoria in 1983, later obtaining a specialist degree in Internal Medicine and Medical Oncology and Master of Philosophy (Palliative Medicine) at the University of Cape Town, South Africa. He is a founding member of the palliative care working group European Society of Medical Oncology and faculty member of ESMO education. In 2009, Dr. Chasen, was Team Leader and Physician, Cancer Nutrition & Rehabilitation Program at McGill University Hospital Complex obtained “Supra regionale de niveau 3” status for the PQCCC. In 2013, Dr. Chasen and the team at Ottawa Hospital cancer centre achieved ESMO Designated Centre of Integrated Oncology and Palliative care.
He currently holds professorships at the Universities of Toronto, McMaster, Ottawa and McGill. He recently received the Elizabeth J Latimer Prize in Palliative Care from Mc Master University.
He has in excess of 100 peer reviewed publications, abstracts and book chapters. Dr. Chasen is the principle investigator of CIHR (Canadian Institutes of Health Research). This MENAC (The Multimodal Exercise/Nutrition/Anti-inflammatory treatment for Cachexia), trial will investigate the addition of the multimodal intervention for patients receiving standard chemotherapy for metastatic cancer. He was also one of the chief investigators for the initial clinical trials on the use of Rolapitant-a novel NKI inhibitor in the treatment of chemo therapy induced nausea and vomiting.
Dr. Chasen has lectured nationally and internationally on rehabilitation of patients with cancer, approaches to treatment of patients with cachexia, chemotherapy induced nausea and vomiting, survivorship and symptom relief.
Dr Chasen was the Regional Palliative care physician lead for Palliative Care- Champlain LHIN from 2009-2015 and is presently the Medical co-lead for the Palliative Care Network in the Central West LHIN.
Marcelo Cypel MD, MSc, FRCSC
Canada Research Chair in Lung Transplantation (Tier 2)
Surgical Director ECLS Program UHN
Thoracic Surgeon, University Health Network
Associate Professor of Surgery
Division of Thoracic Surgery
University of Toronto
Dr. Cypel is a Staff Thoracic Surgeon at University Health Network (UHN) and an Associate Professor of Surgery at the University of Toronto. He is the Surgical Director of the Artificial Lung Program at UHN. He received his MD in 1999 and completed his general surgery and thoracic surgery residency program in 2004. In 2005 he started his post-doctoral research fellowship at the Latner Thoracic Surgery Laboratory. During this time, he developed a new method of lung preservation and donor lung repair called Ex Vivo Lung Perfusion (EVLP). This method is now used clinically in Toronto and in many other centers, and has significantly increased the number of transplantable lungs. He subsequently performed a 3 years fellowship in thoracic oncology, cardiac surgery, and lung transplantation at the University of Toronto. During his training, he has received 13 awards, including the McMurrich Award given for the best fundamental science work by any level trainee in the Department of Surgery and the 1st Annual Zane Cohen Clinical Fellowship Achievement Award from the Canadian Society of Transplantation. He also achieved a large number of 1st and senior author peer review publications including high impact journals such as Science Translational Medicine, The New England Journal of Medicine and The Lancet. His main clinical interests are in artificial lung devices, Ex vivo and In vivo Lung Perfusion and lung transplantation. He has secured over 2 million in peer review funding over the last 5 years including CIHR grants. His international leadership is also evident by chairing the DCD registry within the International Society of Heart and Lung Transplantation. Dr. Cypel currently holds the prestigious Canada Research Chair in Lung Transplantation from the Government of Canada and he is the principal investigator in very innovative clinical trials, such as the use of uncontrolled donation after cardio-circulatory death for lung transplantation and in vivo lung perfusion with chemotherapy to treat patients with lung metastases. He is a Member of the American Association for Thoracic Surgery (AATS) and a Fellow from the Royal College of Physicians and Surgeons of Canada (FRCSC). His list of publications can be found at: https://www.ncbi.nlm.nih.gov/pubmed/?term=cypel%2Cmarcelo
David R. Gandara, MD,
Professor of Medicine Emeritus
University of California at Davis, School of Medicine
Director, Thoracic Oncology Program
UC Davis Comprehensive Cancer Center
David R. Gandara, MD, Professor of Medicine Emeritus at the University of California at Davis (UC Davis) School of Medicine is the Senior Advisor to the Director, and Director of the Thoracic Oncology Program at UC Davis Comprehensive Cancer Center (UCDCCC). He is an internationally known clinician-scientist and lung cancer thought leader. He has led many notable research projects in lung cancer, including early therapeutics trials at various phases, cooperative group trial through the Southwest Oncology Group (SWOG), and translational science projects. He is the clinical director for a National Cancer Institute (NCI) award to the California Cancer Consortium for Early Therapeutic Trials of New Anti-Cancer Agents. He is past chair of the Southwest Oncology Group (SWOG) Lung Committee, and a member and founding co-chair of the NCI-directed Investigational Drug Steering Committee (IDSC). He has written over 700 articles, book chapters, abstracts and editorials. He is Editor-in-chief of the journal Clinical Lung Cancer. He served as president of the International Association for the Study of Lung Cancer (IASLC) from 2009-2011 and served as treasurer from 2013-2017. He is a prior board member and secretary-treasurer of the American Society for Clinical Oncology (ASCO). Most recently, he serves as Clinical Director for the joint Jackson Laboratory (JAX)-UCDCCC patient-derived xenotransplant (PDX) program in lung cancer, and is UCD Comprehensive Cancer Center’s principal investigator for the Stand Up To Cancer (SU2C) dream team in KRAS-mutated lung cancer.
Stephen Lam, MD, FRCPC
Professor of Medicine, Respiratory Division, UBC
Chair, Lung Tumour Group, BC Cancer
Dr. Lam is Professor of Medicine at UBC in the Respiratory Division. He is currently Chair of the Lung Tumour Group and directs the MDS-Rix Early Lung Cancer Detection and Translational Research Program at BC Cancer . He is a Distinguished Scientist in the Department of Integrative Oncology at the BC Cancer Research Centre. Dr. Lam’s research interest is in early detection, chemo prevention, endoscopic diagnosis and treatment of lung cancer. He was the recipient of the Joseph Cullen Award for life – time scientific achievements in lung cancer prevention research by the International Association for the Study of Lung Cancer and the UBC Killam Award.
Leslie Markin, RN
Clinical Trials Nurse Coordinator, BC Cancer
Leslie Markin is a Clinical Trials Nurse Coordinator for the Lung Tumor Group at BC Cancer in Vancouver, Canada. She graduated from University of Alberta Hospital School of Nursing and previously worked in ER and Ambulatory Care Chemotherapy Unit.
Devin Schellenberg, MD, FRCS(C)
Clinical Instructor, Radiation Oncologist
Department of Radiation Oncology
BC Cancer , Abbotsford Centre & Fraser Valley Centre
Dr. Devin Schellenberg is a radiation oncologist practicing in the Fraser Valley and Abbotsford Cancer Centres. He is currently the head of the Clinical Trials Unit at the Abbotsford Cancer Centre and is one of the leaders in the British Columbia stereotactic radiation working group.
His radiation oncology residency was carried out at Princess Margaret Hospital in Toronto and the BC Cancer Agency, after which he completed a fellowship in stereotactic body radiation therapy at Stanford University in 2007.
His present research is focused on the use of novel imaging modalities in radiation therapy.
Paula A. Ugalde Figueroa, MD
Thoracic surgeon – Institut Universitaire de Cardiologie et de Pneumologie de Québec – Université Laval (IUCPQ – UL)
Laval University – Quebec, CA
Doctor Ugalde graduated from Federal University of the Bahia, Brazil. She received a training in General Surgery and Thoracic Surgery at Santa Casa da Misericordia in Porto Alegre. Soon after, she completed a Master’s degree in Medicine and Health – Federal University of the Bahia (2004), Brazil.
To pursue her further training, she applied for an international two-year fellowship at the Quebec Heart and Lung Institute (Institut Universitaire de Cardiologie et de Pneumologie de Québec – Université Laval) and a one-year fellowship at the University of Pittsburgh Medical Center Heart, Lung and Esophageal Surgery Institute.
She is currently the research coordinator in Thoracic Oncology and Thoracic Surgeon at the Institut Universitaire de Cardiologie et de Pneumologie de Québec, Canada.
She is specialized in surgical management of lung cancer and esophageal cancer with a focus on minimally invasive thoracic surgery. As a researcher, she strikes for the development of technology and innovation at the Institut and supervises
Gregory M. M. Videtic, MDCM, FRCPC, FACR, FASTRO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Staff Physician, Department of Radiation Oncology
Cleveland Clinic’s Taussig Cancer Institute
Dr. Videtic is a Staff Physician in the Department of Radiation Oncology of the Cleveland Clinic’s Taussig Cancer Institute and a Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.
He was born in Montreal and attended McGill University where he obtained a B.Sc. with Honors in Physiology, followed by completion of his medical degree. He completed a Residency in Family Medicine at Dalhousie University in Halifax, Nova Scotia, in 1988. He completed a Fellowship in Geriatrics Research at the University of Western Ontario in 1992 then returned there for a Residency in Radiation Oncology, completing it in 1997. He completed a CNS Radiosurgery/Brachytherapy Fellowship in 1998 at Wayne State University in Detroit, MI, under the mentorship of Dr. Laurie Gaspar.
His first staff position was at the London Regional Cancer Centre in London, Ontario. He then moved to the Dana-Farber Cancer Institute, Boston, MA, in 2000, followed by a move to the Cleveland Clinic’s Department of Radiation Oncology in 2003. At the Clinic, he is currently the Director of Thoracic Radiation Oncology, with primary responsibility to leading the lung stereotactic body radiotherapy program since its inception in 2004.
Among other affiliations, he is a member of the Lung Cancer Steering Committee of the Radiation Therapy Oncology Group (RTOG) and was the Principal Investigator for RTOG 0915. He was Senior Editor (Thoracic) for the “International Journal of Radiation Oncology, Biology, Physics” from 2013 to 2016 and is an Executive Editor at “ASTRO’s Advances in Radiation Oncology” Journal since 2016.
John Yee, MD, FRCS(C)
Assistant Professor- Division of Thoracic Surgery, UBC
Director- Lung Transplant Program, VGH
Dr. John Yee is an Assistant Professor-Division of Thoracic Surgery, UBC and Director- Lung Transplant Program, VGH.
Dr. Yee is a designate of the Chair of the UBC Department of Surgery for the Surgical Oncology Network Council Executive.
Kelly Zibrik, MScN, RN
Coordinator, Lung Tumor Group
Kelly Zibrik received her Bachelor in Science in Nursing degree from the University of British Columbia in 2002 and a Masters degree in Nursing from the University of Northern British Columbia in 2009. She has worked at BC Cancer since 2004 in various clinical nursing roles and is currently working as a nurse triage coordinator with the lung tumor group at the Vancouver Centre.